News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Results from the RECOVER-NEURO clinical trial were published in the journal JAMA Neurology. The trial focused on symptoms of cognitive dysfunction associated with Long COVID, including brain fog, trouble focusing, and thinking clearly.
Teams from 4 RECOVER clinical trial sites share their recruitment strategies and their efforts to reach out to and share research opportunities with their local communities.
RECOVER Representatives use their lived experience and feedback from their communities to make recommendations that help make RECOVER-SLEEP trial participation simpler and more accessible.
NIH leaders and RECOVER researchers will provide updates on RECOVER-Treating Long COVID (RECOVER-TLC), the next phase of RECOVER Long COVID clinical trials.
Leveraging staff expertise and consistent monitoring, a RECOVER-ENERGIZE clinical trial is exploring whether a personalized cardiopulmonary rehabilitation program can help people with Long COVID regain physical activity.
This year, RECOVER researchers continue to publish results from research studies that deepen our understanding of Long COVID. RECOVER studies continue, with 2 clinical trials expected to reach enrollment goals this summer.
Five RECOVER study sites across the Pacific Northwest teamed up to form a consortium. Consortium members learn from other RECOVER researchers’ findings and share knowledge with the community.
Patient, Caregiver, and Community Representatives inform RECOVER research, help connect the initiative with different communities, and share news about RECOVER studies.